Navigation Links
Seven Summits Research Releases Alerts on XOM, MER, DRYS, CSC, and PDLI
Date:1/10/2008

CHICAGO, Jan. 10 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.

Seven Summits Strategic Investments' PriceWatch Alerts are available at

http://www.iotogo.com/s/011008B (Note: You may have to copy this link into your browser then press the [ENTER] key.)

Today's PriceWatch Alerts cover the following stocks: Exxon Mobil Corp. (NYSE: XOM), Merrill Lynch & Co., Inc. (NYSE: MER), DryShips, Inc. (Nasdaq: DRYS), Computer Sciences Corp. (NYSE: CSC), and PDL BioPharma Inc. (Nasdaq: PDLI).

Along with our PriceWatch Alerts, these brief reports contain a concise market overview, economic calendar and Dynamic Market Opportunities. PriceWatch Alerts include hedged trade ideas designed to potentially protect investors from unexpected market shifts. While other market reports only provide stock news, we offer strategies that hedge investments against uncertainty. Hedged trades increase your chances of making a profit, even if a stock goes down.

"Our PriceWatch Alerts go beyond other market reports. Along with a brief concise market overview, each PriceWatch Alert provides useful strategies, which ensure potential investments are protected with basic hedging techniques," says Reid Stratton, Seven Summits Senior Analyst. "This brief report contains information that can benefit expert and novice investors who want to stay ahead of the market."

For essential information on stocks poised to move go to:

http://www.iotogo.com/s/011008B for Seven Summits Strategic Investments' PriceWatch Alerts.

Seven Summits Investment Research is an independent investment research group, which focuses on the U.S. equities and options markets. Our analytical tools, screening techniques, rigorous research methods and committed staff provide solid information to help our clients make the best possible investment decisions. For more information go to

http://www.SevenSummitsInvestmentResearch.com. CRD# 137114

Hulbert Financial Digest's No. 1 Rated Stock Picker Reveals His Next Winners FREE. Discover how to take full advantage of the market shift by buying tomorrow's big stocks today at bargain-basement prices! Before you invest one more dime in the Dow, find out which secret stocks will benefit from the strength in the defense sectors, increased consumer spending, and fast-growing earnings! From a commercial construction company that posted 78.4% sales growth over the past 4 quarters, to a global position system company that has handed investors 100% more profits than Apple with earnings growth of 73%! Download your FREE report right now!

http://investorplace.com/order/?pc=9IT100

All stocks and options shown are examples only -- not recommendations to buy or sell. Our picks do not represent a positive or negative outlook on any security. Potential returns do not take into account your trade size, brokerage commissions or taxes -- expenses that will affect actual investment returns. Stocks and options involve risk, thus they are not suitable for all investors. Prior to buying or selling options, a person should request a copy of Characteristics and Risks of Standardized Options available from Catherine at 800-698-9101 or at

http://www.cboe.com/Resources/Intro.aspx. Privacy policy available upon request.


'/>"/>
SOURCE Seven Summits Investment Research
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Pharmacopeia To Present at BMO Capital Markets Seventh Annual Focus on Healthcare Conference
2. MedImmune Announces Seven Key Promotions and New Hires
3. SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting
4. ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007
5. SciQuest Continues to Surpass Milestones for Customer Wins, Growth and Market Share; Remains Clear Eprocurement Leader for Academic and Research-Centric Organizations
6. Researchers use magnetism to target cells to animal arteries
7. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Cyclophosphamide Treatment
8. Research by Case Western Reserve University, VA earns cover of prestigious science publication
9. Dr. Joseph L. Corriveau Appointed Director of Research and Technology
10. Ames Laboratory researchers solve fuel-cell membrane structure conundrum
11. Clemson researcher studies carbon fibers for nuclear reactor safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... organization (CRO) has validated a 0.2 ng/mL lower limit (LLOQ) assay for nicotine ... 0.5 ng/mL LLOQ assay, the ultra-low trace nicotine assay meets additional needs of ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... today announced their digital pathology technology has the potential to eliminate subjectivity in ... centers in The Netherlands as part of the 2017 ISBI CAMELYON Digital ...
(Date:4/27/2017)... ... April 27, 2017 , ... Arrowhead Publishers is pleased to ... coming to San Diego, CA on September 27-28, 2017. Leaders from the pharmaceutical, ... advances in the treatment of various types of pain. There are also extended ...
(Date:4/27/2017)... Orleans, La. (PRWEB) , ... ... ... Monitoring Technologies today announced a comprehensive rebrand and a name change to ... for the industrial and laboratory monitoring of polymer and biopharmaceutical manufacturing processes ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/5/2017)... NEW YORK , April 5, 2017 ... security, is announcing that the server component of the ... is known for providing the end-to-end security architecture that ... customers. HYPR has already secured over 15 ... system makers including manufacturers of connected home product suites ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
Breaking Biology News(10 mins):